These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Merck opts for shake-up to clear drug pipeline. Nature; 2005 Dec; 438(7071):1076-7. PubMed ID: 16371975 [No Abstract] [Full Text] [Related]
8. BARDA funds vaccine makers aiming to phase out eggs. Strauss S Nat Biotechnol; 2010 Dec; 28(12):1227-8. PubMed ID: 21139593 [No Abstract] [Full Text] [Related]
9. Jumpstarting research into neglected diseases. Leslie M Cell; 2006 Nov; 127(3):443-5. PubMed ID: 17081963 [TBL] [Abstract][Full Text] [Related]
10. Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics. Fitzgerald GA Nat Rev Drug Discov; 2005 Oct; 4(10):815-8. PubMed ID: 16224453 [TBL] [Abstract][Full Text] [Related]
11. Drug discovery alliances. Jones A; Clifford L Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845 [No Abstract] [Full Text] [Related]
12. A new era of hope for the world's most neglected diseases. The PLoS Med; 2005 Sep; 2(9):e323. PubMed ID: 16138790 [TBL] [Abstract][Full Text] [Related]
13. The people vs patents. New Sci; 2002 Jul; 175(2351):3. PubMed ID: 12625337 [No Abstract] [Full Text] [Related]
14. EUFEPS report. Contribution of academic research to discovery and development of medicines: current status and future opportunities. Couvreur P; Barguer D; Crommelin DJ; DuchĂȘne D; Engels JW; Kerr DJ; Krogsgaard-Larsen P; Meijer DK; Paoletti R; Wagner E; Eur J Pharm Sci; 2005 Feb; 24(2-3):245-52. PubMed ID: 15776539 [No Abstract] [Full Text] [Related]
15. Compound scale-up at the discovery-development interface. Nikitenko AA Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683 [TBL] [Abstract][Full Text] [Related]
16. Lessons from 54 years of pharmaceutical research. Firestone RA Nat Rev Drug Discov; 2011 Oct; 10(12):963. PubMed ID: 22036986 [No Abstract] [Full Text] [Related]
17. Medicine and the pharmaceutical industry. Baxter P Dev Med Child Neurol; 2006 Aug; 48(8):627. PubMed ID: 16836771 [No Abstract] [Full Text] [Related]
18. The state of innovation in drug development. Kola I Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690 [TBL] [Abstract][Full Text] [Related]
19. The gold industry standard for risk and cost of drug and vaccine development revisited. Pronker ES; Weenen TC; Commandeur HR; Osterhaus AD; Claassen HJ Vaccine; 2011 Aug; 29(35):5846-9. PubMed ID: 21722688 [TBL] [Abstract][Full Text] [Related]
20. A venture capital view of challenges, opportunities, and innovation in biomedical research. Ratcliffe LT Clin Pharmacol Ther; 2011 Feb; 89(2):174-6. PubMed ID: 21252935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]